Treatment of the anti-CD24 neutralizing antibody had little effect on the invasive activity of SP0926 cells (Fig. 4c), as CD24 expression levels are very low in this derivative cancer cells (Fig. 4a). The gene discussed is CD24; the disease is cancer.